Laurel Wealth Advisors (North Carolina)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.7M Buy
5,705,964
+5,675,095
+18,384% +$30.6M 0.44% 50
2025
Q1
$6.47M Sell
30,869
-524
-2% -$110K 1.01% 26
2024
Q4
$5.58M Sell
31,393
-344
-1% -$61.1K 0.87% 30
2024
Q3
$6.27M Sell
31,737
-450
-1% -$88.9K 1% 26
2024
Q2
$5.52M Sell
32,187
-959
-3% -$164K 0.96% 26
2024
Q1
$6.04M Sell
33,146
-134
-0.4% -$24.4K 1.03% 26
2023
Q4
$5.16M Sell
33,280
-64
-0.2% -$9.92K 0.98% 29
2023
Q3
$4.97M Sell
33,344
-2,104
-6% -$314K 1.05% 28
2023
Q2
$4.78M Sell
35,448
-1,185
-3% -$160K 0.96% 30
2023
Q1
$5.84M Buy
36,633
+653
+2% +$104K 1.23% 23
2022
Q4
$5.81M Buy
35,980
+2,788
+8% +$451K 1.32% 20
2022
Q3
$4.46M Buy
33,192
+2,444
+8% +$328K 1.11% 24
2022
Q2
$4.71M Buy
30,748
+765
+3% +$117K 1.14% 26
2022
Q1
$4.86M Sell
29,983
-366
-1% -$59.3K 1.02% 26
2021
Q4
$4.11M Buy
30,349
+1,245
+4% +$169K 0.84% 34
2021
Q3
$3.14M Sell
29,104
-1,318
-4% -$142K 0.69% 46
2021
Q2
$3.43M Buy
30,422
+2,266
+8% +$255K 0.74% 40
2021
Q1
$3.05M Buy
28,156
+2,670
+10% +$289K 0.74% 45
2020
Q4
$2.73M Buy
25,486
+3,545
+16% +$380K 0.71% 45
2020
Q3
$1.92M Buy
21,941
+4,312
+24% +$378K 0.57% 53
2020
Q2
$1.73M Buy
17,629
+6,834
+63% +$671K 0.57% 56
2020
Q1
$822K Buy
10,795
+1,175
+12% +$89.5K 0.31% 73
2019
Q4
$852K Sell
9,620
-195
-2% -$17.3K 0.27% 74
2019
Q3
$743K Sell
9,815
-660
-6% -$50K 0.25% 79
2019
Q2
$762K Sell
10,475
-62
-0.6% -$4.51K 0.27% 77
2019
Q1
$849K Sell
10,537
-360
-3% -$29K 0.31% 72
2018
Q4
$1.01M Buy
+10,897
New +$1.01M 0.4% 66